306 related articles for article (PubMed ID: 19670224)
1. Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
Sfanos KS; Bruno TC; Meeker AK; De Marzo AM; Isaacs WB; Drake CG
Prostate; 2009 Nov; 69(15):1694-703. PubMed ID: 19670224
[TBL] [Abstract][Full Text] [Related]
2. T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.
Wieland A; Kamphorst AO; Adsay NV; Masor JJ; Sarmiento J; Nasti TH; Darko S; Douek DC; Xue Y; Curran WJ; Lawson DH; Ahmed R
Cancer Immunol Immunother; 2018 Nov; 67(11):1767-1776. PubMed ID: 30167863
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
4. Clonality of CD4
Arakawa A; Vollmer S; Tietze J; Galinski A; Heppt MV; Bürdek M; Berking C; Prinz JC
Front Immunol; 2019; 10():1336. PubMed ID: 31275310
[TBL] [Abstract][Full Text] [Related]
5. Relationship between T cell receptor clonotype and PD-1 expression of tumor-infiltrating lymphocytes in colorectal cancer.
Sukegawa K; Shitaoka K; Hamana H; Kobayashi E; Miyahara Y; Fujii K; Tsuda K; Saeki S; Nagata T; Ozawa T; Saito S; Fujii T; Muraguchi A; Shiku H; Kishi H
Eur J Immunol; 2020 Oct; 50(10):1580-1590. PubMed ID: 32441316
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial immunotherapy induces tumor-infiltrating CD8
Van Braeckel-Budimir N; Dolina JS; Wei J; Wang X; Chen SH; Santiago P; Tu G; Micci L; Al-Khami AA; Pfister S; Ram S; Sundar P; Thomas G; Long H; Yang W; Potluri S; Salek-Ardakani S
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903555
[TBL] [Abstract][Full Text] [Related]
7. Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer.
Zhang Y; Huang S; Gong D; Qin Y; Shen Q
Cell Mol Immunol; 2010 Sep; 7(5):389-95. PubMed ID: 20514052
[TBL] [Abstract][Full Text] [Related]
8. Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.
Greenough TC; Campellone SC; Brody R; Jain S; Sanchez-Merino V; Somasundaran M; Luzuriaga K
PLoS One; 2010 Sep; 5(9):e12926. PubMed ID: 20886079
[TBL] [Abstract][Full Text] [Related]
9. Deep sequencing and flow cytometric characterization of expanded effector memory CD8
Giudice V; Feng X; Lin Z; Hu W; Zhang F; Qiao W; Ibanez MDPF; Rios O; Young NS
Haematologica; 2018 May; 103(5):759-769. PubMed ID: 29419434
[TBL] [Abstract][Full Text] [Related]
10. Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer.
Meng Q; Liu Z; Rangelova E; Poiret T; Ambati A; Rane L; Xie S; Verbeke C; Dodoo E; Del Chiaro M; Löhr M; Segersvärd R; Maeurer MJ
J Immunother; 2016; 39(2):81-9. PubMed ID: 26849077
[TBL] [Abstract][Full Text] [Related]
11. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
Gros A; Parkhurst MR; Tran E; Pasetto A; Robbins PF; Ilyas S; Prickett TD; Gartner JJ; Crystal JS; Roberts IM; Trebska-McGowan K; Wunderlich JR; Yang JC; Rosenberg SA
Nat Med; 2016 Apr; 22(4):433-8. PubMed ID: 26901407
[TBL] [Abstract][Full Text] [Related]
12. Analysis of T cell receptor Vbeta diversity in peripheral CD4 and CD8 T lymphocytes in patients with autoimmune thyroid diseases.
Okajima M; Wada T; Nishida M; Yokoyama T; Nakayama Y; Hashida Y; Shibata F; Tone Y; Ishizaki A; Shimizu M; Saito T; Ohta K; Toma T; Yachie A
Clin Exp Immunol; 2009 Feb; 155(2):166-72. PubMed ID: 19040601
[TBL] [Abstract][Full Text] [Related]
13. T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation.
Cerqueira MA; Ferrari KL; de Mattos AC; Monti CR; Reis LO
World J Urol; 2020 Mar; 38(3):673-680. PubMed ID: 31263944
[TBL] [Abstract][Full Text] [Related]
14. Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma.
Ebelt K; Babaryka G; Figel AM; Pohla H; Buchner A; Stief CG; Eisenmenger W; Kirchner T; Schendel DJ; Noessner E
Prostate; 2008 Jan; 68(1):1-10. PubMed ID: 17948280
[TBL] [Abstract][Full Text] [Related]
15. Analysis of TCR Repertoire and PD-1 Expression in Decidual and Peripheral CD8
Morita K; Tsuda S; Kobayashi E; Hamana H; Tsuda K; Shima T; Nakashima A; Ushijima A; Kishi H; Saito S
Front Immunol; 2020; 11():1082. PubMed ID: 32582176
[TBL] [Abstract][Full Text] [Related]
16. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.
Ahmadzadeh M; Johnson LA; Heemskerk B; Wunderlich JR; Dudley ME; White DE; Rosenberg SA
Blood; 2009 Aug; 114(8):1537-44. PubMed ID: 19423728
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
18. Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells.
Inozume T; Hanada K; Wang QJ; Ahmadzadeh M; Wunderlich JR; Rosenberg SA; Yang JC
J Immunother; 2010; 33(9):956-64. PubMed ID: 20948441
[TBL] [Abstract][Full Text] [Related]
19. T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer.
Mercader M; Bodner BK; Moser MT; Kwon PS; Park ES; Manecke RG; Ellis TM; Wojcik EM; Yang D; Flanigan RC; Waters WB; Kast WM; Kwon ED
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14565-70. PubMed ID: 11734652
[TBL] [Abstract][Full Text] [Related]
20. TCR repertoire intratumor heterogeneity of CD4
Zhang C; Ding H; Huang H; Palashati H; Miao Y; Xiong H; Lu Z
Int J Cancer; 2019 Feb; 144(4):818-827. PubMed ID: 30151844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
